Day: April 30, 2021

AUSTIN, TX and DURHAM, NC, April 30, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer, will participate in two upcoming conferences. Presentation DetailsConference: 32nd Annual Cello Health Cancer Progress ConferenceTitle: Multifunctional Soluble Biologics: Binders, Binders Everywhere Format: Panel discussionDate: May 5, 2021Time: 11:45 a.m. EST Conference: 17th Annual PEGS Boston ConferenceTitle: Ranking Product Attributes to Select an Appropriate Expression PlatformFormat: Panel discussionDate: May 11, 2021Time: 12:20 p.m....

SUZHOU and SHANGHAI, China, April 30, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the following upcoming virtual conferences: Morgan Stanley Virtual Asia Healthcare ConferenceOne-on-one and small group meetings: May 13-14, 2021For more information, please contact your Morgan Stanley representative. ICA China Healthcare Corporate DayOne-on-one and small group meetings: May 18, 2021For more information, please contact your ICA representative. Sachs Associates 7th Annual Immuno-Oncology Innovation ForumChinese Innovation in IO Panel: 10:10am EDT, May 20, 2021For more information, please...

VANCOUVER, British Columbia, April 30, 2021 (GLOBE NEWSWIRE) — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce its FY 2020 financial results again highlighted by revenue record numbers. Overview In FY 2020, the Company expanded into new geographic areas and again achieved record revenue numbers, which was driven by annual revenue growth of nearly 32% to approximately $6.3 million (up from $4.8 million in FY 2019). Some highlights of the year included the Company delivering well over 2 million packages, an increase in business with Amazon and onboarding new customers in the B2B space, including in the flower delivery, grocery, pharmaceutical, meal kit deliveries and retail spaces to both further diversify and grow our customer base, while increasing operating margins. Additionally,...

Voxtur achieves 37% year-over-year Revenue growth for fiscal year 2020 TORONTO and TAMPA, Fla., April 30, 2021 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV : VXTR ; OTCQB : ILATF) (“Voxtur” or “the Company”) today announced that its Audited Consolidated Financial Statements for the year ended December 31, 2020 and the related Management’s Discussion and Analysis (“MD&A”) are available at www.sedar.com and on the Company’s website at voxtur.com. In a year of unprecedented challenges resulting from the Covid-19 pandemic, Voxtur persevered to lay a strategic foundation for the future growth and success of the Company. The Company’s 2020 milestones include the completion of an oversubscribed private placement, a substantial increase in credit resources with the Bank of Montreal’s Technology & Innovation Banking Group,...

THIS MEDIA RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATESNEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, April 30, 2021 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Corporation”) (TSX:RSI) announced today the closing of the previously announced private placement of C$100 million 3.49% Senior Guaranteed Notes due April 30, 2031 (the “Notes”) of its wholly-owned subsidiary, Lantic Inc. (“Lantic”). Net proceeds from the issuance of Notes will be used to refinance existing credit facility debt of Lantic. The Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or under any other securities laws. This press release is not an offer of the Notes for sale or a solicitation of an offer to purchase the Notes in the United States or Canada, or in any jurisdiction in which...

SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (the “SEC”) on April 30, 2021. The Company’s annual report on Form 20-F, which contains its audited consolidated financial statements, can be accessed on and downloaded from the SEC’s website at www.sec.gov as well as on the Company’s investor relations website at https://www.anpacbio.com. About AnPac Bio AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 142 issued patents as of March...

Relay is well funded through 2021 with over $9 million CAD in the treasury and will show first commercial revenues in Q2 2021 from initial commercial activities Company is currently scaling up to support commercial activities related to Fionet deployments including LifeLabs partnership and Cybeats sales launch The Cybeats product line is now commercially available with multiple pilots underwayTORONTO, April 30, 2021 (GLOBE NEWSWIRE) — Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) (“Relay” or the “Company“), a developer of technological innovation, is pleased to provide an update on ongoing activities related to the Company’s commercial and development activities. Operations and Finance Following an oversubscribed private placement in January 2021 and warrant exercises in the last quarter, the...

VANCOUVER, British Columbia, April 30, 2021 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to provide an update on recent developments in Greenland with regards to exploration and mining activities and their potential impact on the Skaergaard Project (“Skaergaard”). The Company is in the process of planning a large diamond drilling program on its Skaergaard Project starting in late June to early July with further details to be released soon. Recent election results in Greenland have resulted in a new coalition government that remains very supportive of exploration and mining development in the country. This has been evident with the recent conditional approval and full support of the Company’s exploration and drilling plans for Skaergaard...

WILMINGTON, Del., April 30, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced that it has completed the acquisition of the personal care business from Schülke & Mayr GmbH, a portfolio company of the global investment organization EQT. Under the terms of the agreement, Ashland agreed to a purchase price of €262.5 million in an all-cash transaction funded with bank financing and available cash, subject to customary purchase price adjustments. Ashland expects the acquisition to become immediately accretive to Ashland’s earnings per share. The completion of the acquisition strengthens Ashland’s consumer business portfolio and enhances the company’s specialty additives position while expanding the company’s biotechnology and microbiology technical competencies. The move also advances Ashland’s...